Skip to main content
Debate: Should Patients With CLL Take Breaks From Targeted Therapies?
Primary tabs
•••
View
Get Stamp Tags
Published Locations
Breadcrumb
Home
Debate: Should Patients With CLL Take Breaks From Targeted Therapies?
User login
Username
Password
Reset your password
Concept
Lead
score
Chronic Lymphocytic Leukemia
1
1
Leukemia
0
0.76
Biologic Therapy
0
0.53
Remission
0
0.5
Toxicology
0
0.42
Arrhythmia
0
0.39
COVID-19
0
0.28
Tyrosine Kinase Inhibitor
0
0.24
Cancer
0
0.17
Face
0
0.17
Massachusetts
0
0.17
Monoclonal Antibody
0
0.17
Ohio
0
0.17
Pandemic
0
0.17
Refractory
0
0.17
Sudden Cardiac Death
0
0.17
Travel Medicine
0
0.17
Tyrosine Kinase
0
0.17
Hypertension
0
0.16
Vaccines
0
0.16
Specialty
Lead
score
Hematology-Oncology
1
1
Internal Medicine
0
1
Family Medicine/Primary Care
0
0.94
Public Health & Prevention
0
0.93
Pulmonary Medicine
0
0.74
Cardiology
0
0.72
Pharmacist
0
0.67
Emergency Medicine
0
0.58
Infectious Diseases
0
0.55
Nursing
0
0.28
Edit Tags